What does Form FDA 2636 specifically request?

Form FDA 2636 specifically pertains to the request for methadone detoxification treatment in hospitals. This form is utilized to document and formalize the need for a hospital-based program that provides methadone as part of a comprehensive treatment plan for individuals undergoing detoxification from opioid addiction. The use of methadone in this context is regulated to ensure that it is administered safely and effectively for treating substance use disorders.

When hospitals seek to establish such programs, they must present their proposal through this form, detailing how they will safely implement the methadone treatment and manage patient care. The focus of Form FDA 2636 is entirely on outlining the specifics of the detoxification treatment, which is essential for regulatory compliance and for ensuring that the treatment is provided in adherence to federal guidelines.

This context makes it clear why this particular option is correct, as it centers on the specific need for a hospital to request authorization to provide a vital component of addiction treatment.